Communicating with customers and patients digitally is top of many people’s agenda at the moment – it’s an exciting area …
A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …
It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …
The NHS should use financial incentives to encourage people to make healthier lifestyle changes, according to NICE’s Citizen’s Council. The …
Grünenthal has been severely criticised in two rulings by UK pharma’s self-regulatory body the PMCPA for promoting off-label use of …
Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …
There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …
Helvoet Pharma of Belgium has started officially started construction of a new production facility in India that is scheduled to …
The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …
AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …
AstraZeneca’s oral antiplatelet treatment Brilique has received a positive opinion from a key European advisory committee. A marketing authorisation for …

Amgen has taken what it describes as a precautionary measure and recalled lots of two of its erythropoietin-based products Epogen …
27 September, 2010London, UK Andy Black reappointed as Kinapse Chief Executive The Board of Directors of Kinapse Ltd. today …
Cambridge, UK-based life sciences body One Nucleus has appointed Dr Alan Palmer as a director. Alan is co-founder and chief …
24 September, 2010London, UKThe Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as …
Oxford, UK-based digital healthcare agency Incuna has appointed Matthew Newman as creative director.Matthew will oversee the creative department at Incuna, …
The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
Asthma treatments that target genetic variants found in people susceptible to the condition could be available within the next ten …
Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …